Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-label, Randomized, 12-month, Parallel-group, Non-inferiority Study to Compare the Hemoglobin A1C Metabolism of Pitavastatin Therapy Versus Atorvastatin in Chinese Patients With Prediabetes and Hypertension

NCT03532620 is registered in ClinicalTrials.gov with Jun Tao as lead sponsor.

NCT NCT03532620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03532620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-label, Randomized, 12-month, Parallel-group, Non-inferiority Study to Compare the Hemoglobin A1C Metabolism of Pitavastatin Therapy Versus Atorvastatin in Chinese Patients With Prediabetes and Hypertension
Lead sponsor
Jun Tao
Phase
Phase 4
Overall status
Unknown status
Start date
August 9, 2018
Completion date
September 30, 2020
Enrollment
396 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias, hypertension, prediabetic state